In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
HCA Healthcare Inc (NYSE: HCA) closed the day trading at $324.62 up 2.21% from the previous closing price of $317.61. In other words, the price has increased by $2.21 from its previous closing price. On the day, 1.43 million shares were traded. HCA stock price reached its highest trading level at $324.92 during the session, while it also had its lowest trading level at $317.54.
Ratios:
For a better understanding of HCA, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 39.55 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.17. For the most recent quarter (mrq), Quick Ratio is recorded 0.97 and its Current Ratio is at 1.08.
Wells Fargo Downgraded its Equal Weight to Underweight on November 25, 2024, whereas the target price for the stock was revised from $400 to $320.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 14 ’25 when Berres Jennifer sold 9,533 shares for $322.59 per share. The transaction valued at 3,075,240 led to the insider holds 15,412 shares of the business.
Berres Jennifer bought 9,533 shares of HCA for $3,075,238 on Feb 14 ’25. On Feb 11 ’25, another insider, Reiner Deborah M, who serves as the Former Officer of the company, bought 3,510 shares for $322.39 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HCA now has a Market Capitalization of 82480422912 and an Enterprise Value of 126886748160. As of this moment, HCA’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.76, and their Forward P/E ratio for the next fiscal year is 11.63. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.21. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.13. Its current Enterprise Value per Revenue stands at 1.797 whereas that against EBITDA is 9.156.
Stock Price History:
The Beta on a monthly basis for HCA is 1.45, which has changed by 0.017553806 over the last 52 weeks, in comparison to a change of 0.042615533 over the same period for the S&P500. Over the past 52 weeks, HCA has reached a high of $417.14, while it has fallen to a 52-week low of $289.98. The 50-Day Moving Average of the stock is -0.96%, while the 200-Day Moving Average is calculated to be -6.13%.
Shares Statistics:
Over the past 3-months, HCA traded about 1.73M shares per day on average, while over the past 10 days, HCA traded about 1707210 shares per day. A total of 249.98M shares are outstanding, with a floating share count of 174.51M. Insiders hold about 29.12% of the company’s shares, while institutions hold 65.79% stake in the company. Shares short for HCA as of 1743379200 were 5576020 with a Short Ratio of 3.22, compared to 1740700800 on 5891356. Therefore, it implies a Short% of Shares Outstanding of 5576020 and a Short% of Float of 3.18.
Dividends & Splits
HCA’s forward annual dividend rate is 2.70, up from 2.64 a year ago. Against a Trailing Annual Dividend Yield of 0.008312082The stock’s 5-year Average Dividend Yield is 0.8.
